![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, January 07, 2022 4:17:03 PM
Potti Manish Director Dec 16 Option Exercise 1.43 45,000 64,530 45,000 Dec 17 09:24 PM
Musunuri Shankar Chief Executive Officer Dec 16 Sale 5.22 115,000 600,300 1,145,299 Dec 17 09:23 PM
Musunuri Shankar Chief Executive Officer Nov 16 Sale 8.04 115,000 924,600 1,260,299 Nov 18 04:07 PM
Zhang Junge Director Nov 03 Sale 17.32 150,300 2,603,196 731,431 Nov 05 04:06 PM
Kompella Uday Director Nov 02 Sale 16.01 25,000 400,250 154,416 Nov 03 07:38 PM
Potti Manish Director Nov 02 Sale 15.07 63,429 955,875 27,695 Nov 03 07:36 PM
Castillo Kirsten Director Nov 02 Sale 15.00 15,000 225,000 50,000 Nov 03 07:35 PM
Zhang Junge Director Nov 02 Sale 15.75 149,700 2,357,775 881,731 Nov 03 07:34 PM
Musunuri Shankar Chief Executive Officer Nov 01 Option Exercise 0.51 115,367 58,837 521,367 Nov 03 07:38 PM
Kompella Uday Director Nov 01 Sale 14.05 25,000 351,250 179,416 Nov 03 07:38 PM
Musunuri Shankar Chief Executive Officer Nov 01 Sale 14.15 115,367 1,632,443 406,000 Nov 03 07:38 PM
Subramanian Sanjay Chief Financial Officer Oct 26 Sale 11.07 10,000 110,700 35,591 Oct 27 05:09 PM
Kompella Uday Director Oct 26 Sale 12.05 25,000 301,250 204,416 Oct 27 04:55 PM
Kompella Uday Director Oct 25 Sale 9.08 46,371 421,049 229,416 Oct 27 04:55 PM
Kompella Uday Director Oct 21 Sale 9.01 1,898 17,101 275,787 Oct 22 07:58 PM
Kompella Uday Director Oct 20 Sale 9.02 1,731 15,614 277,685 Oct 20 06:57 PM
Kumar Ramesh Director Oct 18 Option Exercise 0.51 7,500 3,825 7,500 Oct 20 06:56 PM
Kompella Uday Director Oct 18 Sale 8.41 200,000 1,682,000 279,416 Oct 20 06:57 PM
Kumar Ramesh Director Oct 18 Sale 8.13 7,500 60,975 0 Oct 20 06:56 PM
Musunuri Shankar Chief Executive Officer Oct 15 Option Exercise 0.33 125,000 41,250 531,000 Oct 15 04:02 PM
Subramanian Sanjay Chief Financial Officer Oct 15 Option Exercise 2.19 7,990 17,498 53,581 Oct 15 04:01 PM
Subramanian Sanjay Chief Financial Officer Oct 15 Sale 9.96 7,990 79,580 45,591 Oct 15 04:01 PM
Musunuri Shankar Chief Executive Officer Oct 15 Sale 9.80 125,000 1,225,000 406,000 Oct 15 04:02 PM
Recent OCGN News
- Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease • GlobeNewswire Inc. • 06/21/2024 11:00:00 AM
- Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication • GlobeNewswire Inc. • 06/20/2024 10:30:31 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/18/2024 08:29:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:31:02 PM
- Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy • GlobeNewswire Inc. • 05/31/2024 12:36:49 PM
- Ocugen to Present at BIO International Convention 2024 • GlobeNewswire Inc. • 05/29/2024 11:15:00 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/28/2024 08:05:59 PM
- Ocugen Set to Join Russell 3000® Index Effective June 28, 2024 • GlobeNewswire Inc. • 05/28/2024 11:02:39 AM
- Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024 • GlobeNewswire Inc. • 05/20/2024 11:00:52 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/17/2024 08:30:54 PM
- Ocugen Announces Dosing Completion of Subjects with Stargardt Disease in Cohort 2 of Phase 1/2 GARDian Clinical Trial of OCU410ST—A Modifier Gene Therapy • GlobeNewswire Inc. • 05/15/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 07:54:50 PM
- Ocugen Provides Business Update with First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/14/2024 12:00:25 PM
- US Futures Remain Steady Amid Wall Street Caution Ahead of April PPI Report • IH Market News • 05/14/2024 11:18:01 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 10:32:02 AM
- Form 8-A12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 05/10/2024 08:15:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:14:11 PM
- Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock • GlobeNewswire Inc. • 05/10/2024 08:05:06 PM
- Ocugen to Present at May 2024 Investor Conferences • GlobeNewswire Inc. • 05/10/2024 11:45:07 AM
- Ocugen to Host Conference Call on Tuesday, May 14 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/03/2024 11:30:05 AM
- Ocugen Announces CSO to Present on Modifier Gene Therapy at Retina World Congress • GlobeNewswire Inc. • 05/02/2024 11:15:46 AM
- Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024 • GlobeNewswire Inc. • 04/29/2024 10:45:00 AM
- UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting • GlobeNewswire Inc. • 04/26/2024 01:05:24 PM
- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting • GlobeNewswire Inc. • 04/26/2024 10:30:40 AM
- Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy • GlobeNewswire Inc. • 04/19/2024 11:13:05 AM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM